SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Jan 1998
- 420-6 p. digital
Publication Type: Journal Article
0022-3565
Animals Anti-Inflammatory Agents--pharmacology Cyclohexanecarboxylic Acids--pharmacology Dose-Response Relationship, Drug Female Gastric Acid--metabolism Humans In Vitro Techniques Male Nitriles Phosphodiesterase Inhibitors--pharmacology Pyrrolidinones--pharmacology Rabbits Rolipram